title: Molecularly targeted therapies for human hepatocellular carcinoma: should we start from β-catenin inhibition?
authors.affiliation: Institute of Pathology, University of Greifswald, Greifswald, Germany. Electronic address: diego.calvisi@uni-greifswald.de.
authors.forename: Diego F
authors.initials: DF
authors.lastname: Calvisi
mesh_terms: D000818:Animals; D063646:Carcinogenesis / Q000235:genetics*; D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics*; D008114:Liver Neoplasms, Experimental / Q000235:genetics*; D008297:Male; D009154:Mutation; D009841:Oligonucleotides / Q000378:metabolism*; D051176:beta Catenin / Q000235:genetics*
chemical_list: C495267:CTNNB1 protein, mouse; D004273:DNA, Neoplasm; D009841:Oligonucleotides; D051176:beta Catenin; C477371:locked nucleic acid